医学临床研究
   Jun. 8, 2025    Home  |  About Journal  |  Editorial Board  |  Instruction  |  Subscribe  |  Advertisement  |  Messages Board  |  Contact Us  |  中文
JOURNAL OF CLINICAL RESEARCH  2024, Vol. 41 Issue (3): 368-370    DOI: 10.3969/j.issn.1671-7171.2024.03.013
Original Articles Current Issue | Archive | Adv Search |
Evaluation Value of FT3 and FT4 Levels in Patients with Hyperthyroidism Complicated with Hyperthyroid Heart Disease
LI Dan, HUANG Feng
Department of Clinical Laboratory, Chang'an District Hospital, Xi'an Shaanxi 710119
Download: PDF (1186 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      
Abstract  【Objective】To explore the evaluation value of serum free triiodothyronine(FT3) and free thyroxine(FT4) in patients with hyperthyroidism complicated with hyperthyroid heart disease. 【Methods】A total of 84 patients with hyperthyroidism treated in Chang'an District Hospital from January 2021 to January 2023 were selected in the study. The incidence of hyperthyroidism patients complicated with hyperthyroidism heart disease was counted, and patients were divided into concurrent group(10 cases) and non-concurrent group(74 cases) according to whether hyperthyroidism heart disease occurred. The clinical data of patients in concurrent group and non-concurrent group were compared. Multivariate logistic regression analysis was used to analyze the risk factors of hyperthyroidism patients complicated with hyperthyroidism heart disease. The efficacy of FT3 and FT4 in the evaluation of hyperthyroidism patients complicated with hyperthyroidism heart disease was analyzed. 【Results】There were 10 cases of hyperthyroid patients complicated with hyperthyroid heart disease, which showed that the incidence of hyperthyroid heart disease was 11.90%. There were no significant differences in gender, age, diabetes mellitus, smoking history, hyperthyroidism drug use, uric acid, triglyceride, hemoglobin, albumin and infection between the concurrent group and the non-concurrent group(P>0.05). FT3 and FT4 in the concurrent group were higher than those in the non-concurrent group(P<0.05). The results of multivariate analysis showed that both FT3 and FT4 were independent risk factors for hyperthyroid patients complicated with hyperthyroid heart disease(OR=3.256, 3.368, P<0.05). The best cutoff points of FT3 and FT4 in predicting hyperthyroidism complicated with hyperthyroidism heart disease were 10.25 pmol/L and 36.52 pmol/L respectively, and the area under the curve(AUC) was 0.785 and 0.756. The specificity of the combination of FT3 and FT4 was 92.69%, which was higher than that of FT3 and FT4 alone(P<0.05). 【Conclusion】The incidence of hyperthyroid patients complicated with hyperthyroid heart disease is high. FT3 and FT4 have certain value in the evaluation of hyperthyroid patients complicated with hyperthyroid heart disease, but the value of their combined detection is even higher, which can be used as an important reference index for clinical evaluation.
Key wordsHyperthyroidism/CO      Heart Diseases/ET      Triiodothyronine/BL      Thyroxine/BL     
Received: 25 April 2023     
PACS:  R581.1  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
LI Dan
HUANG Feng
Cite this article:   
LI Dan,HUANG Feng. Evaluation Value of FT3 and FT4 Levels in Patients with Hyperthyroidism Complicated with Hyperthyroid Heart Disease[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(3): 368-370.
URL:  
http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.03.013     OR     http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I3/368
Copyright © Editorial Board of JOURNAL OF CLINICAL RESEARCH
Supported by:Beijing Magtech